NCT00850434
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- Sleep & Chest Disorders Centre Sydney, New South Wales, Australia
Clinical trial condition
Dyssomnias
Explore clinical trials studying Dyssomnias. Study availability and eligibility vary by location and protocol.
4,808 public trials
712 recruiting studies
Dyssomnias trial results
NCT00773721
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- Resmed Centre for Healthy Sleep Sydney, New South Wales, Australia
NCT04296721
- Conditions
- Apnea, Behavior, Body Weight, +20 more
- Locations
-
- Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
NCT01847846
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- ResMed Ltd Bella Vista, New South Wales, Australia
NCT00659100
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site Bonita, California, United States
- Pfizer Investigational Site Fallbrook, California, United States
- Pfizer Investigational Site Hacienda Heights, California, United States
NCT00667108
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Orlando, Florida, United States
- Pfizer Investigational Site Boise, Idaho, United States
Completed
A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects
NCT00666796
- Conditions
- Dyssomnias, Insomnia, Mental Disorders, +4 more
- Locations
-
- Pfizer Investigational Site Miami, Florida, United States
NCT00666575
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Beverly Hills, California, United States
- Pfizer Investigational Site San Francisco, California, United States
Completed
A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
NCT00163046
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Glendale, California, United States
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
NCT02782780
- Conditions
- Dyssomnias, Gulf War Illness, Insomnia, +5 more
- Locations
-
- San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States